Time to Move the Goalposts? Examining Strategies to Advance HBV Management

Learn key strategies from expert faculty on advancing HBV management, including early initiation of treatment and the role of quantitative HBsAg monitoring in clinical practice.

Share

Program Content

Activities

Future HBV Management
The Future of HBV Management: Earlier Treatment and Biomarker Use
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 18, 2023

HBV Management
Practical Insights on HBV Management, HDV screening, and HCC risk
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2023

Activities

HBV Management Strategies
Time to Move the Goalposts? Examining Strategies to Advance HBV Management
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2023

Activities

Quantitative HBsAg Testing
Role of Quantitative HBsAg Testing in Clinical Practice for People With CHB
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 29, 2023

Indications for HBV Treatment
Which Patients With Hepatitis B Should We Be Treating?
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 29, 2023

Activities

Advance HBV Management
Time to Move the Goalposts? Examining Strategies to Advance HBV Management
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2023

Expires: December 12, 2024

Faculty

cover img faculity

Ira Jacobson, MD

Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York

cover img faculity

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This educational activity is supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline